Concord Medical Services Holdings Limited (CCM)
NYSE: CCM · Real-Time Price · USD
5.80
+0.32 (5.84%)
Oct 9, 2025, 4:00 PM EDT - Market closed
CCM Revenue
Concord Medical Services Holdings had revenue of 200.62M CNY in the half year ending June 30, 2025, a decrease of -29.49%. This brings the company's revenue in the last twelve months to 365.76M, down -22.46% year-over-year. In the year 2024, Concord Medical Services Holdings had annual revenue of 383.96M, down -28.55%.
Revenue (ttm)
365.76M CNY
Revenue Growth
-22.46%
P/S Ratio
0.47
Revenue / Employee
614,724 CNY
Employees
595
Market Cap
25.18M USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 383.96M | -153.45M | -28.55% |
Dec 31, 2023 | 537.40M | 65.32M | 13.84% |
Dec 31, 2022 | 472.09M | -13.55M | -2.79% |
Dec 31, 2021 | 485.63M | 262.62M | 117.76% |
Dec 31, 2020 | 223.01M | 24.65M | 12.43% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
CCM News
- 13 days ago - Concord Medical Reports Financial Results for the First Half of 2025 - PRNewsWire
- 3 months ago - Concord Healthcare Announces Completion of China's First Proton Therapy for Choroidal Malignant Melanoma - PRNewsWire
- 4 months ago - Concord Healthcare Announces Official Release of the Proton Therapy Large Model - PRNewsWire
- 5 months ago - Concord Medical Files Annual Report on Form 20-F for Fiscal 2024 - PRNewsWire
- 9 months ago - Concord Medical Announces Result of 2024 Annual General Meeting - PRNewsWire
- 10 months ago - Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate - PRNewsWire
- 11 months ago - Concord Medical Schedules 2024 Annual Meeting of Shareholders - PRNewsWire
- 1 year ago - Concord Medical Reports Financial Results for the First Half of 2024 - PRNewsWire